The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Johnson & Johnson

NYSE: JNJ
Last

(U.S.) $116.85

Today's change+0.30 +0.26%
Updated June 28 9:49 AM EDT. Delayed by at least 15 minutes.
 

Johnson & Johnson

NYSE: JNJ
Last

(U.S.) $116.85

Today's change+0.30 +0.26%
Updated June 28 9:49 AM EDT. Delayed by at least 15 minutes.

Johnson & Johnson up (U.S.)$0.30

Johnson & Johnson is up today by (U.S.)$0.30 or 0.26% to (U.S.)$116.85. Over the last five days, shares have gained 0.58% and 13.76% year to date. Shares have outperformed the S&P 500 by 20.95% during the last year.

Key company metrics

  • Open(U.S.) $117.17
  • Previous close(U.S.) $116.55
  • High(U.S.) $117.17
  • Low(U.S.) $116.55
  • Bid / Ask(U.S.) $116.85 / (U.S.) $116.87
  • YTD % change+13.76%
  • Volume805,822
  • Average volume (10-day)7,864,364
  • Average volume (1-month)7,125,365
  • Average volume (3-month)7,434,494
  • 52-week range(U.S.) $81.79 to (U.S.) $117.74
  • Beta0.55
  • Trailing P/E21.30×
  • P/E 1 year forward17.64×
  • Forward PEG2.94×
  • Indicated annual dividend(U.S.) $3.20
  • Dividend yield2.74%
  • Trailing EPS(U.S.) $5.49
Updated June 28 9:49 AM EDT. Delayed by at least 15 minutes.
S&P TSX1.13%Sector:HealthcareIndustry:Pharmaceuticals - Diversified
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2016Q4/2015Q3/2015Q2/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedApr 03, 201604/03/2016Jan 03, 201601/03/2016Sep 27, 201509/27/2015Jun 28, 201506/28/2015
Revenue17,48217,81117,10217,787
Total other revenue--------
Total revenue17,48217,81117,10217,787
Gross profit12,17012,13811,87812,430
Total cost of revenue5,3125,6735,2245,357
Total operating expense12,18814,05312,98012,046
Selling / general / administrative4,6885,8915,0815,384
Research & development2,0132,8642,1542,129
Depreciation / amortization--------
Interest expense (income), net operating160160123131
Unusual expense (income)137723100
Other operating expenses, total-37-1,205412-1,055
Operating income5,2943,7584,1225,741
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax5,2943,7584,1225,741
Income after tax4,2923,2153,3584,516
Income tax, total1,0025437641,225
Net income4,2923,2153,3584,516
Total adjustments to net income--------
Net income before extra. items4,2923,2153,3584,516
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items4,2923,2153,3584,516
Inc. avail. to common incl. extra. items4,2923,2153,3584,516
Diluted net income4,2923,2153,3584,516
Dilution adjustment----00
Diluted weighted average shares2,7952,8002,8072,812
Diluted EPS excluding extraordinary itemsvalue per share1.541.151.201.61
Dividends per sharevalue per share0.750.750.750.75
Diluted normalized EPSvalue per share1.541.571.201.61